MYCN is the only highly expressed gene from the core amplified domain in human neuroblastomas

Jill Reiter, Garrett M. Brodeur

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

MYCN amplification in neuroblastomas is strongly associated with advanced stages of disease and a poor prognosis. We have recently defined a 130 kb core region of the MYCN amplicon that is consistently amplified in neuroblastomas. However, it has been argued that other expressed sequences were coamplified with MYCN and, as a result, might contribute to the aggressive phenotype of MYCN-amplified neuroblastomas. Therefore, we have screened cosmids representing the core MYCN-amplified domain and surrounding DNA by using a differential hybridization approach to detect other amplified, highly expressed genes from this region. Our results suggest that MYCN is the only highly expressed gene consistently amplified in human neuroblastomas, and that the MYCN gene is likely to be the only selective marker for genomic amplification in these tumors.

Original languageEnglish (US)
Pages (from-to)134-140
Number of pages7
JournalGenes Chromosomes and Cancer
Volume23
Issue number2
DOIs
StatePublished - Oct 1998
Externally publishedYes

Fingerprint

Neuroblastoma
Genes
Cosmids
Phenotype
DNA
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Genetics

Cite this

MYCN is the only highly expressed gene from the core amplified domain in human neuroblastomas. / Reiter, Jill; Brodeur, Garrett M.

In: Genes Chromosomes and Cancer, Vol. 23, No. 2, 10.1998, p. 134-140.

Research output: Contribution to journalArticle

@article{d27e28bcfe3e43d9a35e62210255dc42,
title = "MYCN is the only highly expressed gene from the core amplified domain in human neuroblastomas",
abstract = "MYCN amplification in neuroblastomas is strongly associated with advanced stages of disease and a poor prognosis. We have recently defined a 130 kb core region of the MYCN amplicon that is consistently amplified in neuroblastomas. However, it has been argued that other expressed sequences were coamplified with MYCN and, as a result, might contribute to the aggressive phenotype of MYCN-amplified neuroblastomas. Therefore, we have screened cosmids representing the core MYCN-amplified domain and surrounding DNA by using a differential hybridization approach to detect other amplified, highly expressed genes from this region. Our results suggest that MYCN is the only highly expressed gene consistently amplified in human neuroblastomas, and that the MYCN gene is likely to be the only selective marker for genomic amplification in these tumors.",
author = "Jill Reiter and Brodeur, {Garrett M.}",
year = "1998",
month = "10",
doi = "10.1002/(SICI)1098-2264(199810)23:2<134::AID-GCC6>3.0.CO;2-3",
language = "English (US)",
volume = "23",
pages = "134--140",
journal = "Genes Chromosomes and Cancer",
issn = "1045-2257",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - MYCN is the only highly expressed gene from the core amplified domain in human neuroblastomas

AU - Reiter, Jill

AU - Brodeur, Garrett M.

PY - 1998/10

Y1 - 1998/10

N2 - MYCN amplification in neuroblastomas is strongly associated with advanced stages of disease and a poor prognosis. We have recently defined a 130 kb core region of the MYCN amplicon that is consistently amplified in neuroblastomas. However, it has been argued that other expressed sequences were coamplified with MYCN and, as a result, might contribute to the aggressive phenotype of MYCN-amplified neuroblastomas. Therefore, we have screened cosmids representing the core MYCN-amplified domain and surrounding DNA by using a differential hybridization approach to detect other amplified, highly expressed genes from this region. Our results suggest that MYCN is the only highly expressed gene consistently amplified in human neuroblastomas, and that the MYCN gene is likely to be the only selective marker for genomic amplification in these tumors.

AB - MYCN amplification in neuroblastomas is strongly associated with advanced stages of disease and a poor prognosis. We have recently defined a 130 kb core region of the MYCN amplicon that is consistently amplified in neuroblastomas. However, it has been argued that other expressed sequences were coamplified with MYCN and, as a result, might contribute to the aggressive phenotype of MYCN-amplified neuroblastomas. Therefore, we have screened cosmids representing the core MYCN-amplified domain and surrounding DNA by using a differential hybridization approach to detect other amplified, highly expressed genes from this region. Our results suggest that MYCN is the only highly expressed gene consistently amplified in human neuroblastomas, and that the MYCN gene is likely to be the only selective marker for genomic amplification in these tumors.

UR - http://www.scopus.com/inward/record.url?scp=0031662458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031662458&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2264(199810)23:2<134::AID-GCC6>3.0.CO;2-3

DO - 10.1002/(SICI)1098-2264(199810)23:2<134::AID-GCC6>3.0.CO;2-3

M3 - Article

VL - 23

SP - 134

EP - 140

JO - Genes Chromosomes and Cancer

JF - Genes Chromosomes and Cancer

SN - 1045-2257

IS - 2

ER -